相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Flecainide-Associated Bradycardia-Dependent Torsade de Pointes: Another Potential Mechanism of Proarrhythmia
Han Sang Kim et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2013)
Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium Sensitivity
Joshua D. Lovelock et al.
CIRCULATION RESEARCH (2012)
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence
Roberto Spoladore et al.
EUROPEAN HEART JOURNAL (2012)
Pathophysiology of the cardiac late Na current and its potential as a drug target
Jonathan D. Moreno et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Ranolazine Safely Decreases Ventricular and Atrial Fibrillation in Timothy Syndrome (LQT8)
Dipak P. Shah et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2012)
Role of ranolazine in angina, heart failure, arrhythmias, and diabetes
Samuel Sossalla et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Mechanisms of atrial-selective block of Na+ channels by ranolazine: I. Experimental analysis of the use-dependent block
Andrew C. Zygmunt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIδC can be reversed by inhibition of late Na+ current
Samuel Sossalla et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
The Antianginal Agent Ranolazine is a Potent Antiarrhythmic Agent that Reduces Ventricular Arrhythmias: Through a Mechanism Favoring Inhibition of Late Sodium Channel
Robert A. Kloner et al.
CARDIOVASCULAR THERAPEUTICS (2011)
Ranolazine for the Treatment of Heart Failure With Preserved Ejection Fraction: Background, Aims, and Design of the RALI-DHF Study
Claudius Jacobshagen et al.
CLINICAL CARDIOLOGY (2011)
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations
Tamas Szel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model
Tuomo Nieminen et al.
HEART RHYTHM (2011)
Electrophysiologic basis for the antiarrhythmic actions of ranolazine
Charles Antzelevitch et al.
HEART RHYTHM (2011)
Improvement in Left Ventricular Systolic and Diastolic Performance During Ranolazine Treatment in Patients With Stable Angina
Vincent M. Figueredo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2011)
Suppression of Re-Entrant and Multifocal Ventricular Fibrillation by the Late Sodium Current Blocker Ranolazine
Norishige Morita et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug-Refractory ICD Shocks
T. Jared Bunch et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2011)
Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts
Mohammed Aldakkak et al.
PHARMACOLOGICAL RESEARCH (2011)
Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers
Hua Rong Lu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Sodium Channel (Dys)Function and Cardiac Arrhythmias
Carol Ann Remme et al.
CARDIOVASCULAR THERAPEUTICS (2010)
Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure
Nidas A. Undrovinas et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2010)
Late Na+ Current Inhibition by Ranolazine Reduces Torsades de Pointes in the Chronic Atrioventricular Block Dog Model
Gudrun Antoons et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Ranolazine-Treatment of Ventricular Tachycardia and Symptomatic Ventricular Premature Beats in Ischemic Cardiomyopathy
Sudip Nanda et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2010)
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion
Arvinder K. Dhalla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Increased late sodium currents are related to transcription of neuronal isoforms in a pressure-overload model
Yutao Xi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
A Novel Mechanism for the Treatment of Angina, Arrhythmias, and Diastolic Dysfunction: Inhibition of Late I-Na Using Ranolazine
Lars S. Maier
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine
N. Lindegger et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes:: similarities and differences
Victor A. Maltsev et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes
Yejia Song et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure
Sharad Rastogi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Calcium cycling and signaling in cardiac myocytes
Donald M. Bers
ANNUAL REVIEW OF PHYSIOLOGY (2008)
The cardiac persistent sodium current: an appealing therapeutic target?
D. A. Saint
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Ranolazine Shortens Repolarization in Patients with Sustained Inward Sodium Current Due to Type-3 Long-QT Syndrome
Arthur J. Moss et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2008)
Rapid kinetic interactions of ranolazine with HERG K plus current
Sridharan Rajamani et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia
Xiu Q. Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - Role of late sodium current and intracellular ion accumulation
Samuel Sossalla et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Late sodium current inhibition as a new cardioprotective approach
Sharon L. Hale et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: A case report
David K. Murdock et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2008)
Pathophysiology and pharmacology of the cardiac late sodium current
Antonio Zaza et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Sinus node dysfunction in ATX-II-induced in-vitro murine model of long QT3 syndrome and rescue effect of ranolazine
Jingjing Wu et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2008)
Late sodium current in failing heart: Friend or foe?
Victor A. Maltsev et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2008)
Cardiac sodium channel overlap syndromes: Different faces of SCN5A mutations
Carol Ann Remme et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of Arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome - Thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Randomized controlled trial
Benjamin M. Scirica et al.
CIRCULATION (2007)
Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation - Differences in sodium channel inactivation between atria and ventricles and the role of ranolazine
Alexander Burashnikov et al.
CIRCULATION (2007)
Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: Effects of ranolazine
Serge Sicouri et al.
HEART RHYTHM (2007)
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes - The MERLIN-TIMI 36 randomized trial
David A. Morrow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Long-term safety of a novel antianginal armant in patients with severe chronic stable angina - The Ranolazine Open Label Experience (ROLE)
Michael J. Koren et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Arrhythmogenic ion-channel remodeling in the heart: Heart failure, myocardial infarction, and atrial fibrillation
Stanley Nattel et al.
PHYSIOLOGICAL REVIEWS (2007)
Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action
Sandra Fredj et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD
Carol Ann Remme et al.
CIRCULATION (2006)
Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit
Sharon L. Hale et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts
Heather Fraser et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Antianginal efficacy of ranolazine when added to treatment with amlodipine - The ERICA (Efficacy of Ranolazine In Chronic Angina) Trial
Peter H. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction
Yejia Song et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
L. Belardinelli et al.
HEART (2006)
Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload
D Noble et al.
HEART (2006)
Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome:: A long-term follow-up
G Mönnig et al.
HEART RHYTHM (2005)
Increased late sodium current in myocytes from a canine heart failure model and from failing human heart
CR Valdivia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome
W Shimizu et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
BR Chaitman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Electrophysiological changes in heart failure and their relationship to arrhythmogenesis
MJ Janse
CARDIOVASCULAR RESEARCH (2004)
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties
C Antzelevitch et al.
CIRCULATION (2004)
Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome
L Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes
YJ Song et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Ranolazine:: Ion-channel-blocking actions and in vivo electrophysiological effects
G Schram et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism
I Splawski et al.
CELL (2004)
[Na+]i handling in the failing human heart
B Pieske et al.
CARDIOVASCULAR RESEARCH (2003)
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure
MP Chandler et al.
CIRCULATION RESEARCH (2002)
Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine
AA Paul et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the ΔKPQ SCH5A sodium channel gone mutation
W Zareba et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Late sodium current is a novel target for amiodarone: Studies in failing human myocardium
VA Maltsev et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
分享论文
